AVXL Description — Anavex Life Sciences Corp

Anavex Life Sciences is a clinical stage biopharmaceutical company engaged in the development of therapeutics by applying medicine to central nervous system (CNS) diseases. Co.'s primary compound, ANAVEX®2-73, is being developed to treat Alzheimer's disease, Parkinson's disease and other CNS diseases, including rare diseases, such as Rett syndrome. Co.'s proprietary SIGMACEPTOR™ Discovery Platform produced small molecule drug candidates with certain modes of action, based on its understanding of sigma receptors. Compounds that have been subjects of Co.'s research include the following: ANAVEX®3-71, ANAVEX®1-41, ANAVEX®1066, and ANAVEX®1037.

Company Name: 
Anavex Life Sciences Corp
Drugs & Pharmaceuticals
Number of ETFs Holding AVXL: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   AVXL Weight   AVXL Amount 
 XBI   0.71%   $51,524,094         
 VTI   0.00%   $31,837,815         
 IWM   0.04%   $24,292,705         
 VXF   0.01%   $17,215,275         
 IWO   0.07%   $8,456,194         
 PTH   1.57%   $8,318,099         
 VHT   0.02%   $3,543,831         
 IWC   0.21%   $2,588,025         
 LABU   0.38%   $2,540,509         
 VTWO   0.03%   $2,340,888         
List of all 23 ETFs holding AVXL »
Quotes delayed 20 minutes

Strong Buy (4.00 out of 4)
97th percentile
(ranked higher than approx. 97% of all stocks covered)

Analysts Forecast:
AVXL Price Target

Based on data provided by Zacks Investment Research via

ETFs Holding AVXL | Anavex Life Sciences Corp | ETF Channel |

Copyright © 2010 - 2021, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.